Bellevue Group »

Miragen Therapeutics shares owned by Bellevue Group

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Bellevue Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $653k 30k 21.78
2023-09-30 $978k 64k 15.34
2023-06-30 $1.1M 44k 23.79
2023-03-31 $1.2M 46k 25.44
2022-12-31 $1.3M 46k 29.21
2022-09-30 $946k 46k 20.52
2022-06-30 $567k 49k 11.57